InvestorsHub Logo
Followers 17
Posts 1755
Boards Moderated 0
Alias Born 11/13/2013

Re: Hamoa post# 260180

Thursday, 04/02/2020 8:35:41 AM

Thursday, April 02, 2020 8:35:41 AM

Post# of 426052
Hamoa - You hit on something that bothers me (well, much bothers me). You said;

"On appeal, I think it likely that the panel will look at Mori and, at best (for Amarin), say, “This study, given its small size, low trig level population, different baseline trig levels between the EPA and DHA arms, etc, does not clearly render the Amarin patents obvious."

I totally agree. Can the appeals court look at Du's use of Mori? What I'm getting at is there is much talk how she erred in her methodology, however, she also totally screwed the pooch on the technical side as well. Mori proved nothing with regards to TG > 500.

To me, that in itself, should be grounds for overturning Du. She completely whiffed on the science/technical stuff.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News